0MUR4KZ
Supplement Ankle Bursa and Ligament, Left to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | M Bursae and Ligaments |
| Operation | U Supplement |
| Body Part | R Ankle Bursa and Ligament, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a bursa or, much more commonly, a ligament that remains largely intact but needs additional structural support. A typical example is augmenting a partially torn ligament with a collagen patch, mesh, or allograft strip to bolster its strength without removing and fully replacing the native tissue.
This approach is chosen when a ligament has enough healthy tissue to preserve but is not strong enough on its own to withstand normal joint stress, often in cases of chronic laxity, partial tearing, or degenerative thinning. It is also used in some reconstructive techniques that combine native ligament preservation with graft augmentation, an increasingly common alternative to full replacement for certain knee and ankle ligament injuries. The added material integrates with the existing structure over time, aiming to restore joint stability while keeping as much of the patient's own tissue as possible.
Anatomy & Axis Detail
Ankle Bursa and Ligament, Left
On the left ankle, the bursa and ligament group covers the lateral collateral ligaments, deltoid ligament, and periarticular bursae responsible for maintaining joint stability during weight-bearing and gait. Recurrent inversion injuries can leave these ligaments chronically lax, and surgeons frequently address this by reinforcing the native tissue with graft material rather than excising and replacing it. This supplementation approach preserves the existing ligamentous framework while restoring the tension needed for functional stability, distinguishing it from procedures that fully reconstruct a torn ligament. Precise identification of the reinforced structure in the operative note is important given the number of distinct ligaments in this compact anatomic region.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders assign Supplement when the operative note describes reinforcing an existing bursa or ligament with graft, mesh, or other material while the native structure is left in place, not excised. Key language includes "augmented," "reinforced," or "buttressed with graft." The most frequent error is confusing this with Replacement - if the surgeon documents that the damaged ligament was removed before the new material was placed, Replacement is correct instead. Coders should also confirm the supplementing material is a recognized device or biologic value, since the device character of the procedure affects code selection.